Lord, Abbett & Co’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.57M | Buy |
|
|||||
|
2025
Q1 | $1.94M | Buy |
|
|||||
|
2024
Q4 | $765K | Buy |
|
|||||
|
2024
Q3 | $314K | Sell |
|
|||||
|
2024
Q2 | $5.92M | Sell |
|
|||||
|
2024
Q1 | $80.9M | Buy |
|
|||||
|
2023
Q4 | $8.91M | Sell |
|
|||||
|
2023
Q3 | $7.42M | Sell |
|
|||||
|
2023
Q2 | $98.2M | Buy |
|
|||||
|
2023
Q1 | $70.8M | Sell |
|
|||||
|
2022
Q4 | $119M | Buy |
|
|||||
|
2022
Q3 | $7.5M | Sell |
|
|||||
|
2022
Q2 | $13.9M | Buy |
|
|||||
|
2022
Q1 | $22.4M | Sell |
|
|||||
|
2021
Q4 | $197M | Sell |
|
|||||
|
2021
Q3 | $244M | Buy |
|
|||||
|
2021
Q2 | $22M | Buy |
|
|||||
|
2021
Q1 | $8.15M | Sell |
|
|||||
|
2020
Q4 | $68.1M | Sell |
|
|||||
|
2020
Q3 | $91.7M | Buy |
|
|||||
|
2020
Q2 | $86.3M | Sell |
|
|||||
|
2020
Q1 | $118M | Buy |
|
|||||
|
2019
Q4 | $82.2M | Buy |
|
|||||
|
2019
Q3 | $38.1M | Buy |
|
|||||
|
2019
Q2 | $34.7M | Sell |
|
|||||
|
2019
Q1 | $27.8M | Sell |
|
|||||
|
2018
Q4 | $59.9M | Buy |
|
|||||
|
2018
Q3 | $50.9M | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $7.35M | Sell |
|
|||||
|
2017
Q1 | $18.3M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $44.8M | Buy |
|
|||||
|
2016
Q2 | $16.9M | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $35.9M | Sell |
|
|||||
|
2015
Q2 | $40.6M | Sell |
|
|||||
|
2015
Q1 | $50.5M | Sell |
|
|||||
|
2014
Q4 | $59.2M | Sell |
|
|||||
|
2014
Q3 | $47.2M | Buy |
|
|||||
|
2014
Q2 | $26.9M | Sell |
|
|||||
|
2014
Q1 | $47M | Sell |
|
|||||
|
2013
Q4 | $46.5M | Sell |
|
|||||
|
2013
Q3 | $53.9M | Sell |
|
|||||
|
2013
Q2 | $51.2M | Buy |
|